tiprankstipranks
Trending News
More News >
Lexston Life Sciences Corp. (TSE:LEXT)
:LEXT
Canadian Market
Advertisement

Lexston Life Sciences Corp. (LEXT) Income Statement

Compare
5 Followers

Lexston Life Sciences Corp. Income Statement

Last quarter (Q4 2025), Lexston Life Sciences Corp.'s total revenue was C$0.00, a decrease of ― from the same quarter last year. In Q4, Lexston Life Sciences Corp.'s net income was C$-437.12K. See Lexston Life Sciences Corp.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
C$ 0.00C$ 0.00C$ 0.00C$ 361.01KC$ 149.11K
Gross Profit
C$ 0.00C$ -26.39KC$ -29.80KC$ 241.49KC$ 60.10K
Operating Expenses
C$ 1.35MC$ 707.89KC$ 1.04MC$ 2.11MC$ 551.19K
Depreciation and Amortization
C$ 0.00C$ 26.39KC$ 29.80KC$ 31.98KC$ 11.27K
EBITDA
C$ -1.54MC$ -648.32KC$ -841.73KC$ -2.29MC$ -479.82K
Operating Income
C$ -1.35MC$ -674.72KC$ -871.53KC$ -2.00MC$ -491.09K
Other Income/Expenses
C$ -194.99KC$ -59.56KC$ -94.54KC$ -320.59KC$ -385.04K
Pretax Income
C$ -1.54MC$ -734.28KC$ -966.07KC$ -2.32MC$ -876.13K
Net Income
C$ -1.62MC$ -867.71KC$ -1.11MC$ -2.32MC$ -876.13K
Per Share Metrics
Basic EPS
C$ -0.34C$ -0.23C$ -0.34C$ -2.08C$ -0.88
Diluted EPS
C$ -0.34C$ -0.27C$ -0.39C$ -2.08C$ -0.88
Weighted Average Shares Outstanding
4.75M 3.77M 3.28M 1.12M 999.37K
Weighted Average Shares Outstanding (Diluted)
4.75M 3.19M 2.86M 1.12M 999.37K
Currency in CAD

Lexston Life Sciences Corp. Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis